BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Artificial Intelligence

AI-Designed Drug Enters Phase II Trials, First Patients Dosed by Insilico Medicine

After completing the Phase 0 and Phase I human safety studies, INS018_055, Insilico's AI-discovered and AI-generated drug, has ent...

June 28, 2023 | News

Japan Approves CXR-AID for Reimbursement, Boosting Market Expansion for Lunit

Lunit (KRX:328130.KQ), a global provider of cancer diagnostics solutions, today announced that CXR-AID, FujiFilm's AI solution for chest X-ray analysis, po...

June 27, 2023 | News

South Korea's DeepCatch AI Software Receives US FDA Clearance for Whole-Body CT Quantification

The world's first FDA cleared solution that automatically analyzes bone, muscle, visceral fat, subcutaneous fat, internal organ, and central nerv...

June 27, 2023 | News

FUJIFILM Irvine Scientific Enhances Life Whisperer Platform for IVF Clinical Decision-Making

FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the Life Science and Medical markets, tod...

June 23, 2023 | News

Cognizant and Accuray Partner to Drive Operational Efficiency in Radiation Therapy Business

Cognizant (NASDAQ: CTSH) announced that it is partnering with Accuray Incorporated (NASDAQ: ARAY) to support the company's deplo...

June 22, 2023 | News

Beaconcure Raises $14 Million Series B to Expand AI-powered Clinical Technology Platform

NewVale Capital leads $14 Million Series B growth round Industry leading executive, Rick Riegel, joins as Chairman of the Board Newly formed Strategic ...

June 14, 2023 | News

Lunit's Groundbreaking AI Research Transforms Medical Pathology with Computer Vision, Presented at CVPR 2023

Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer diagnostic solutions, announced its participation in the Conference on Computer...

June 13, 2023 | News

HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vincere Biosciences for Parkinson's Disease Collaboration

HanAll Biopharma and Daewoong Pharmaceutical have co-invested in Vincere Biosciences. These mission-aligned companies are collaborating to develop small...

June 13, 2023 | News

Nucleai & Mayo Clinic Partner to Revolutionize Digital Pathology in Drug Development & Clinical Practice

This collaboration combines Nucleai’s AI-powered spatial biology technology with Mayo’s longitudinally annotated, multi-modal data sets, world-...

June 05, 2023 | News

GC Biopharma Licensed to Build Plasma Fractionation Plant in Indonesia

GC Biopharma, a South Korean biopharmaceutical company, announced on Jun. 1st that it has successfully obtained final approval from the Indonesia...

June 02, 2023 | News

Lunit and the JNCCHE Partner in AI Pathology to Advance Precision Oncology

Lunit (KRX:328130.KQ), a global provider of AI-powered cancer diagnostic solutions, today announced collaboration with the National Cancer Center...

May 31, 2023 | News

United Imaging Unveils AI-Driven Product Portfolio at CMEF 2023

The booth was divided into three main areas: integrated diagnosis and treatment, precision diagnosis, and prospective research. United Imaging's most cutti...

May 18, 2023 | News

MEDICAL IP utilizes NVIDIA Omniverse to develop virtual Medical Digital Twins

MEDIP PRO, a real-time digital twin implementation solution based on medical imaging, is now connected to NVIDIA Omniverse Maximize medical data...

May 09, 2023 | News

Cambridge Infinitus Research Centre Launches AI-based ERnet Platform for Cellular Health Studies.

With an impact factor of 47.99, Nature Methods is the world's leading international publication for biochemical research methodology. Upon public...

May 05, 2023 | News

Stay Connected